Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maxcyte (MXCT) Long-Term Debt Repayments (2021)

Historic Long-Term Debt Repayments for Maxcyte (MXCT) over the last 1 years, with Q1 2021 value amounting to $4.9 million.

  • Maxcyte's Long-Term Debt Repayments changed N/A to $4.9 million in Q1 2021 from the same period last year, while for Dec 2021 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $4.9 million for FY2021, which is 24183.33% up from last year.
  • Latest data reveals that Maxcyte reported Long-Term Debt Repayments of $4.9 million as of Q1 2021.
  • Over the past 5 years, Maxcyte's Long-Term Debt Repayments peaked at $4.9 million during Q1 2021, and registered a low of $4.9 million during Q1 2021.